Citation

McDaniel KF, Wang L, Soltwedel T, Fidanze SD, Hasvold LA, Liu D, Mantei RA, Pratt JK, Sheppard GS, Bui MH, Faivre EJ, Huang X, Li L, Lin X, Wang R, Warder SE, Wilcox D, Albert DH, Magoc TJ, Rajaraman G, Park CH, Hutchins CW, Shen JJ, Edalji RP, Sun CC, Martin R, Gao W, Wong S, Fang G, Elmore SW, Shen Y, Kati WM.: Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor. J Med Chem, Volume 60 (20), 2017

Authors

Albert DH, Bui MH, Edalji RP, Elmore SW, Faivre EJ, Fang G, Fidanze SD, Gao W, Hasvold LA, Huang X, Hutchins CW, Kati WM., Li L, Lin X, Liu D, Magoc TJ, Mantei RA, Martin R, McDaniel KF, Park CH, Pratt JK, Rajaraman G, Shen JJ, Shen Y, Sheppard GS, Soltwedel T, Sun CC, Wang L, Wang R, Warder SE, Wilcox D, Wong S

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.7b00746

PubMed

28949521

Machine-readable

REST APIRDF